The 3 analysts offering 12-month price forecasts for Corbus Pharmaceuticals Holdings Inc have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 1.40. The median estimate represents a +109.86% increase from the last price of 0.95.
The current consensus among 4 polled investment analysts is to Hold stock in Corbus Pharmaceuticals Holdings Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Nov 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.